List view / Grid view
Prashant Khadayate, Pharma Analyst at GlobalData, explains what the current state of the COVID-19 pandemic is in India and what vaccine options are currently under development/testing.
A batch of Nitrofurantoin and all unexpired stock of Desmopressin nasal spray are being recalled in the UK, the MHRA has announced.
The FDA has announced that Dr Reddy's is recalling Phytonadione injectable emulsion because of complaints due to ampules breaking and shattering.
According to the MHRA, the finasteride 5mg tablets produced by Dr Reddy’s do not contain certain warnings and precautions in the patient information leaflets.
The US District Court has ruled in favour of Eli Lilly in the Alimta patent lawsuit against Dr. Reddy's Laboratories and Hospira, Inc.
The FDA has announced that it has granted approval to the first nine generic drug applications for Pfizer’s Lyrica treatment.
6 August 2015 | By Victoria White
Dr. Reddy’s has entered into a strategic collaboration with Amgen to distribute three Amgen medicines in India in the areas of oncology and cardiology...
1 April 2015 | By Victoria White
UCB has announced it has entered an agreement with Dr. Reddy’s to sell its established brands in India, allowing it to focus on its neurology portfolio...
28 April 2011 | By POZEN Inc.
AstraZeneca and POZEN have filed a patent infringement lawsuit against Dr. Reddy's relating to VIMOVO(TM)...
12 April 2011 | By Project PR
Dr. Reddy’s Laboratories has announced the opening of its newly expanded Chirotech Technology Centre...
